نتائج البحث - Ziling Liu

  • يعرض 1 - 15 نتائج من 15
تنقيح النتائج
  1. 1
    Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease

    Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease حسب Chengfei Xu, Ziling Liu, Jiangwei Xiao

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Placental chorioangioma and pregnancy outcome: a ten-year retrospective study in a tertiary referral centre

    Placental chorioangioma and pregnancy outcome: a ten-year retrospective study in a tertiary referral centre حسب Hongwei Ma, Ziling Liu, Jie Ruan

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer

    Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer حسب Xi Chen, Xu Wang, Hua He, Ziling Liu, Ji‐Fan Hu, Wěi Li

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Immunotherapy: a promising approach for glioma treatment

    Immunotherapy: a promising approach for glioma treatment حسب Feroza Yasinjan, Xing Yang, Huayue Geng, Rui Guo, Lei Yang, Ziling Liu, Hong Wang

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer

    ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer حسب Lin Hou, Xueying Zhang, Yan Jiao, Yanqing Li, Yue‐Chen Zhao, Yinuo Guan, Ziling Liu

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Bibliometric study of immunotherapy for hepatocellular carcinoma

    Bibliometric study of immunotherapy for hepatocellular carcinoma حسب Zhiyi Li, Ying Zhang, B Zhang, Rui Guo, He Min-Hua, Ziling Liu, Lei Yang, Hong Wang

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    DOT1L complex regulates transcriptional initiation in human erythroleukemic cells

    DOT1L complex regulates transcriptional initiation in human erythroleukemic cells حسب Aiwei Wu, Junhong Zhi, Tian Tian, Ali Cihan, Murat Cevher, Ziling Liu, Yael David, Tom W. Muir, Robert G. Roeder, Ming Yu

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study

    Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study حسب Zihua Zou, Puyuan Xing, Xuezhi Hao, Yan Wang, Xia Song, Shan Li, Cuiying Zhang, Ziling Liu, Kewei Ma, Guilan Dong, Junling Li

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

    Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers حسب Jun Shen, Ziling Liu, Nevins W. Todd, Howard Zhang, Jipei Liao, Lei Yu, Maria Guarnera, Ruiyun Li, Ling Cai, Min Zhan, Feng Jiang

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials

    Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials حسب Xing Yang, Feroza Yasinjan, Yajie Du, Huayue Geng, Ying Zhang, Minghua He, Rui Guo, Lei Yang, Jiayue Cui, Dongmei Mu, Ziling Liu, Hong Wang

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer

    Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer حسب Tiantian Wang, Jie Tang, Hongying Yang, Rutie Yin, Jingru Zhang, Qi Zhou, Ziling Liu, Lanqin Cao, Li Li, Yi Huang, Kui Jiang, Wei Wang, Fenglin She, Ni Guan, Zhiguo Hou, Ning Li, Lingying Wu

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03

    Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03 حسب Xinan Sheng, Haige Chen, Bin Hu, Xudong Yao, Ziling Liu, Xin Yao, Hongqian Guo, Yi Hu, Zhigang Ji, Hong Luo, Benkang Shi, Jiyan Liu, Jin Wu, Fangjian Zhou, Zhisong He, Jinhai Fan, Weifeng Wang, Hui Feng, Sheng Yao, Patricia Keegan, Yong Huang, Jun Guo

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials

    Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis... حسب Xinan Sheng, Lin Wang, Zhisong He, Yanxia Shi, Hong Luo, Weiqing Han, Xin Yao, Benkang Shi, Jiyan Liu, Chang-Lu Hu, Ziling Liu, Hongqian Guo, Guohua Yu, Zhigang Ji, Jianming Ying, Yun Ling, Shiying Yu, Yi Hu, Jianming Guo, Jianmin Fang, Aiping Zhou, Jun Guo

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer

    Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer حسب Ning Li, Jianqing Zhu, Rutie Yin, Jing Wang, Lingya Pan, Beihua Kong, Hong Zheng, Jihong Liu, Xiaohua Wu, Li Wang, Yi Huang, Ke Wang, Dongling Zou, Hongqin Zhao, Chunyan Wang, Weiguo Lü, Lin An, Ge Lou, Guiling Li, Pengpeng Qu, Hongying Yang, Yu Zhang, Hongbing Cai, Yueyin Pan, Min Hao, Ziling Liu, Heng Cui, Yingjie Yang, Shuzhong Yao, Xiaoa Zhen, Wenzhao Hang, Jianmei Hou, Juan Wang, Lingying Wu

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial

    Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase... حسب Xiaohua Wu, Jianqing Zhu, Rutie Yin, Jiaxin Yang, Jihong Liu, Jing Wang, Lingying Wu, Ziling Liu, Yunong Gao, Danbo Wang, Ge Lou, Hongying Yang, Qi Zhou, Beihua Kong, Yi Huang, Lipai Chen, Guiling Li, Ruifang An, Ke Wang, Yu Zhang, Xiaojian Yan, Xin Lü, Weiguo Lu, Min Hao, Li Wang, Heng Cui, Qionghua Chen, Guzhalinuer Abulizi, Xianghua Huang, Xiaofei Tian, Hao Wen, Zhao Huang, Juan Dong, Charlie Zhang, Jianmei Hou, Mansoor Raza Mirza

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: